Transcranial Magnetic Stimulation (TMS) is a non-invasive procedure that delivers magnetic pulses to the brain to change neural activity. It is used to treat mental health disorders, particularly ...
As a noninvasive neuromodulation method, transcranial magnetic stimulation (TMS) shows great potential to treat a range of mental and psychiatric diseases, including major depression. Current methods ...
With its policy change, Cigna now joins several other major insurers that cover the device, including Centene, Highmark, Blue Cross Blue Shield, Tricare and Palmetto GBA. More than 86 million adults ...
Soterix Medical Inc., the global leader in non-invasive stimulation and integrated brain monitoring technologies, announced today clearance from the U.S. Food & Drug Administration (FDA) for the SPRY ...
MALVERN, Pa., Sept. 21, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, developing and marketing products that improve ...
BURLINGTON, Mass. and JERUSALEM, Jan. 10, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (BWAY) (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation ...
For patients with schizophrenia, repetitive transcranial magnetic stimulation (rTMS) was effective and safe in treating auditory verbal hallucinations, according to a randomized sham-controlled trial.
Not all patients with depression respond to medication. Two recently published studies provide additional information on how an alternative treatment, transcranial magnetic stimulation (TMS), could be ...
Not many researchers get the chance to float, weightless, 32,000 feet above the Earth. Medical University of South Carolina scientists usually conduct research in labs – controlled settings where they ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results